Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gauthier Bouche

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Cancer Management and Research|March 6, 2025
Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer PatientsEvelyn Hewitt, Gauthier Bouche, Alexandre Costa Alencar, et al.
Neuro-Oncology Advances|August 11, 2021
A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3Marc-Eric Halatsch, Richard E Kast, Georg Karpel-Massler, et al.
Ecancermedicalscience|September 18, 2014
Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, MilanGauthier Bouche, Nicolas André, Shripad Banavali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201Jordan R Hansford, Gauthier Bouche, Vijay Ramaswamy, et al.
Cancer Treatment Reviews|August 11, 2025
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancersSilvia Stacchiotti, Pan Pantziarka, Hugh Leonard, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Cancer Management and Research|March 6, 2025
Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer PatientsEvelyn Hewitt, Gauthier Bouche, Alexandre Costa Alencar, et al.
Neuro-Oncology Advances|August 11, 2021
A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3Marc-Eric Halatsch, Richard E Kast, Georg Karpel-Massler, et al.
Ecancermedicalscience|September 18, 2014
Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, MilanGauthier Bouche, Nicolas André, Shripad Banavali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201Jordan R Hansford, Gauthier Bouche, Vijay Ramaswamy, et al.
Cancer Treatment Reviews|August 11, 2025
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancersSilvia Stacchiotti, Pan Pantziarka, Hugh Leonard, et al.
Pageof 7